biomedicina slovenica


angiotensin : 308

  1. Makuc Jana; Šeruga Maja; Završnik Matej; Cilenšek Ines; Petrovič Danijel
    Angiotensinogen (AGT) gene missense polymorphisms (rs699 and rs4762) and diabetic nephropathy in Caucasians with type 2 diabetes mellitus
    2017
  2. Šeruga Maja; Makuc Jana; Završnik Matej; Cilenšek Ines; Ekart Robert; Petrovič Danijel
    Polymorphism of angiotensin-converting enzyme (rs4340) and diabetic nephropathy in Caucasians with type 2 diabetes mellitus
    2016
  3. Trošt Rupnik Alijana; Kovač Damjan; Pajek Jernej; Osredkar Joško; Marc Janja; Lindič Jelka
    The impact of gene polymorphisms in angiotensin receptor 1 and aldosterone synthase in peritoneal dialysis patients
    2017
  4. Ristić Smiljana; Starčević-Čizmarević Nada; Lavtar Polona; Lovrečić Luca; Perković Olivio; Sepčić Juraj; Šega Saša; Kapović Miljenko; Peterlin Borut
    Angiotensin-converting enzyme insertion/deletion gene polymorphism and interferon-[beta] treatment response in multiple sclerosis patients
    2017
  5. Cafuta Maček Eva; Košnik Mitja; Korošec Peter
    Pogostost, patogeneza in dejavniki tveganja za nastanek angiodema ob prejemanju zaviralcev angiotenzinove konvertaze
    2015
  6. Merlo Sebastjan; Novák J; Tkáčová N; Nikolajević-Starčević Jovana; Šantl-Letonja Marija; Makuc Jana; Cokan Vujkovac Andreja; Letonja Jaušovec Lidija; Bregar Dejan; Zorc Marjeta; Rojko Maksimiljana; Mankoč Ramuš Sara; Kruzliak Peter; Petrovič Danijel
    Association of the ACE rs4646994 and rs4341 polymorphisms with the progression of carotid atherosclerosis in Slovenian patients with type 2 diabetes mellitus
    2015
  7. Pereza Nina; Ostojić Saša; Zdravčević Matea; Volk Marija; Kapović Miljenko; Peterlin Borut
    Insertion / deletion polymorphism in intron 16 of ACE gene in idiopathic recurrent spontaneous abortion
    2016
  8. Meglič Dušanka; Miksić Mirjana; Zagradišnik Boris; Gregorič Alojz
    Genetic di[s]position for essential hypertension in children of mothers with preeclampsia
    2007
  9. Poredoš Pavel; Ježovnik Mateja
    Do the effects of secondary prevention of cardiovascular events in PAD patients differ from other atherosclerotic disease?
    2015
  10. Rupnik Erik; Kariž Stojan; Iglič Črtomir; Zidarn Mihaela; Košnik Mitja
    Življenje ogrožajoči angioedem po zaviralcu angiotenzinove konvertaze - prikaz dveh primerov
    [Life-threatening angioedema induced by angiotensin-converting enzyme inhibitor - two case reports]
    2015
  11. Ademosun Ayokunle O.; Oboh Ganiyu; Passamonti Sabina; Tramer Federica; Žiberna Lovro; Boligon Aline Augusti; Athayde Margareth Linde
    Phenolics from grapefruit peels inhibit HMG-CoA reductase and angiotensin-I converting enzyme and show antioxidative properties in endothelial EA.Hy 926 cells
    2015
  12. Terčelj-Zorman Marjeta; Salobir Barbara; Zupančič Mirjana; Rylander Ragnar
    Sarcoidosis treatment with antifungal medication
    2014
  13. Hodošček-Majc Lea; Lainščak Mitja
    Heart failure pharmacotherapy guideline implementation and survival of patients in a community hospital
    [Udejanjanje smernic za zdravljenje srčnega popuščanja in preživetje bolnikov v regijski bolnišnici]
    2014
  14. Pal Marjetka; Ferk Polonca
    Interakcije zdravil z zaviralci angiotenzinske konvertaze
    [Drug interactions with angiotensin-converting enzyme inhibitors]
    2012
  15. Janić Miodrag; Lunder Mojca; Šabovič Mišo
    Arterial stiffness and cardiovascular therapy
    2014
  16. Pal Marjetka; Ferk Polonca; Leskošek Branimir
    Ambulantno predpisovanje antihipetenzivov in kakovost nadzora arterijske hipertenzije v Sloveniji
    [Outpatient prescribing of antihypertensives and quality of arterial hypertension control in Slovenia]
    2014
  17. Lunder Mojca; Drevenšek Gorazd; Černe Marko; Marc Janja; Janić Miodrag; Šabovič Mišo
    Treatment with low-dose atorvastatin, losartan, and their combination increases expression of vasoactive-related genes in rat aortas
    2013
  18. Janić Miodrag; Lunder Mojca; Šabovič Mišo
    #A #new anti-ageing strategy focused on prevention of arterial ageing in the middle-aged population
    2013
  19. Trošt Rupnik Alijana; Pajek Jernej; Guček Andrej; Osredkar Joško; Kovač Damjan; Bren Andrej; Klančič Dimitrij; Saksida Silvana; Rus Igor; Globokar Mateja; Drozg Andrej; Lešnik Marjeta; Plešivčnik Zala; Ekart Robert; Kralj Lopert Simona; Lindič Jelka
    Influence of renin-angiotensin-aldosterone system-blocking drugs on peritoneal membrane in peritoneal dialysis patients
    2013
  20. Lunder Mojca; Drevenšek Gorazd; Šabovič Mišo
    Zaščitni pleiotropni učinki nizkih odmerkov statinov in zaviralcev sistema renin-angiotenzin na delovanje srčno-žilnega sistema
    2012
  21. Klupka-Sarić Inge; Peterlin Borut; Lovrečić Luca; Sinanović Osman; Vidović Mirjana; Sehanović Aida; Starčević-Čizmarević Nada; Sepčić Juraj; Kapović Miljenko; Ristić Smiljana
    Angiotensin-Converting Enzyme Gene Polymorphism in Patients with Multiple Sclerosis from Bosnia and Herzegovina
    2011
  22. Lunder Mojca; Janić Miodrag; Skralovnik Ajda; Turk Martina; Habjan Sara; Šabovič Mišo
    Staranje arterijskega sistema
    [Arterial aging]
    2012
  23. Lunder Mojca; Janić Miodrag; Žiberna Lovro; Drevenšek Gorazd; Šabovič Mišo
    A low-dose atorvastatin and losartan combination directly improves aortic ring relaxation and diminishes ischaemic-reperfusion injury in isolated rat hearts
    2012
  24. Tomasik Tomasz; Windak Adam; Jozwiak Jacek; Oleszczyk Marek; Seifert Bohumil; Kersnik Janko; Kryj-Radziszewska Elzbieta
    Treatment of hypertension in central and eastern European countries: self-reported practice of primary care physicians
    2012
  25. Šantl-Letonja Marija; Letonja Mitja; Nikolajević-Starčević Jovana; Popovič Dražen; Petrovič Danijel
    Is there an association between the angiotensin converting enzyme gene polymorphism and carotid atherosclerosis in non-insulin-dependent diabetics?
    2010
  26. Trobec Katja; von Haehling Stephan; Anker Stefan D; Lainščak Mitja
    Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia
    2011
  27. Doehner Wolfram; Todorović Johanna; Kennecke Cornelia; Rauchhaus Mathias; Sandek Anja; Lainščak Mitja; van Linthout Sophie; Tschoepe Carsten; von Haehling Stephan; Anker Stefan D
    Improved insulin sensitivity by the angiotensin receptor antagonist irbesartan in patients with systolic heart failure: a randomized double-blinded placebo-controlled study
    2012
  28. Springer Jochen; Lainščak Mitja; Salobir Barbara; Lang Irene M
    Treatment of pulmonary hypertension: bench to bedside
    2011
  29. Bevc Sebastjan
    Aldosteron, zaviralci aldosteronskih receptorjev in kronična ledvična bolezen
    [Aldosterone, aldosterone receptor blockers and chronic kidney disease]
    2011
  30. Camm AJ; Kirchhof P; Lip GY; Zupan I
    Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)
    2010
  31. Janić Miodrag; Lunder Mojca; Šabović Mišo
    Okrnjeno delovanje endotelija
    [Endothelial dysfunction]
    2011
  32. Štimac Danijela; Polić-Vižintin Marina; Škes Marija; Cattunar Albert; Cerović Robert; Stojanović Dražen
    Utilization of cardiovascular drugs in Zagreb 2001-2005
    2010
  33. Pal Marjetka; Leskošek Brane L; Ferk Polonca
    Poraba antihipertenzivnih zdravil v Sloveniji in primerjava z Norveško
    [Consumption of antihypertensives in Slovenia and comparison with Norway]
    2011
  34. Vrtovec Bojan; Poglajen Gregor
    Sodobni načini zdravljenja srčnega popuščanja
    [Modern treatment methods for heart failure]
    2011
  35. Terčelj Marjeta; Salobir Barbara; Zupančič Mirjana; Rylander Ragnar
    Antifungal medication is efficient in the treatment of sarcoidosis
    2011
  36. Bajuk-Studen Katica; Šebeštjen Miran; Pfeifer Marija; Preželj Janez
    Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
    2011
  37. Terčelj Marjeta; Salobir Barbara; Rylander Ragnar
    Anti-fungal medication and sarcoidosis
    [Antimikotiki in sarkoidoza]
    2010
  38. Rozentryt Piotr; von Haehling Stephan; Lainščak Mitja; Nowak Jolanta U; Lalantar-Zafeh Kamyar; Polonski Lech; Anker Stefan D
    The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study
    2010
  39. Sinkovič Andreja
    Age-related short-term effect of ramipril on N-terminal pro-brain natriuretic peptide and markers of hemostasis in patients after acute myocardial infarction
    2010
  40. Zupan Igor; Lipar Luka
    Doseganje ciljne srčne frekvence, antiishemična učinkovitost in prenašanje zdravila ivabradin pri bolnikih s stabilno angino pektoris (raziskava OPTIMAL 60)
    [Target heart rate achievement, antiishemic drug efficacy and tolerability of ivabradin in patients with stable angina pectoris (OPTIMAL 60 study)]
    2010
  41. Ružič-Medvešček Nada; Pitamic Samo
    Antagonisti aldosteronskih receptorjev in srčno popuščanje
    [Aldosterone receptor antagonists in chronic heart failure]
    2010
  42. Zajc Milita; Zupan Anton; Bunc Matjaž
    Prizadetost srca pri mišičnih in živčno-mišičnih obolenjih
    [Cardiac involvement in muscle and neuromuscular disorders]
    2010
  43. Stoka Veronika; Turk Vito
    A structural approach to understand the cross-talk of the kallikrein-kinin and the renin-angiotensin systems
    2010
  44. Hojs Radovan
    Zavora renin-angiotenzin-aldosteronskega sistema (RAAS) - več kot le zdravljenje hipertenzije?
    [Renin angiotensin aldosterone system (RAAS) blockade - more than antihypertensive treatment?]
    2010
  45. Sinkovič Andreja
    Bolnik z akutnim miokardnim infarktom - ukrepi ob akutnem dogodku in ukrepanje v bolnišnici
    2010
  46. Pongrac-Barlovič Draženka; Cooper Mark E
    Diabetes: RAS inhibition: probably not a one-size-fits-all approach
    2009
  47. Pongrac-Barlovič Draženka; Thomas Merlin C; Jandeleit-Dahm Karin
    Cardiovascular disease: what's all the AGE/RAGE about?
    2010
  48. Šinigoj Petra; Lunder Mojca; Šinigoj Martin; Drevenšek Gorazd; Šabovič Mišo
    The preventive cardiovascular effect of a combination of statin and angiotensin receptor blocker at sub-therapeutic doses in middle-aged healthy volunteers
    2009
  49. Šušteršič Miha; Bunc Matjaž
    Nova spoznanja o reninsko-angiotenzinskemu sistemu s poudarkom na (pro)reninu in (pro)reninskem receptorju ter možnostih njune zavore
    [New knowledge of renin-anginotensin-aldosterone system with emphasis on (pro)renin, (pro)renin receptor and possibilities of their blockade]
    2009
  50. Marinšek Martin; Sinkovič Andreja
    A randomized trial comparing the effect of ramipril and losartan in survivors of ST-elevation myocardial infarction
    2009
  51. Lainščak Mitja; Coletta Alison P; Sherwi Nasser; Cleland John G
    Clinical trials update from the Heart failure society of America meeting 2009: FAST, IMPROVE-HF, COACH galectin-3 substudy, HF-ACTION nuclear substudy, DAD-HF, and MARVEL-1
    2009
  52. Terčelj Marjeta; Salobir Barbara; Simčič Saša; Wraber Branka; Zupančič Mirjana; Rylander Ragnar
    Chitotriosidase activity in sarcoidosis and some other pulmonary diseases
    2009
  53. Geršak Ksenija; Cvijic Marta; Kornhauser-Cerar Lilijana
    Angiotensin II receptor blockers in pregnancy: a report of five cases
    2009
  54. Magdič Jožef
    Pleotropni učinki zdravil v preventivi možganskožilnih bolezni
    [Pleiotrophic effects of drugs used for stroke prevention]
    2009
  55. Bombek Mirko
    Ali z izbiro antihipertenzivnega zdravljenja lahko upočasnimo razvoj srčnožilnih bolezni in njihovih posledic?
    [Are we able to slow down the progress of cardiovascular diseases and their fatal events with proper choice of antihipertensive treatment?]
    2009
  56. Azarija Jelena; Peternel Polona
    Ambulantno zdravljenje venske tromboze
    [Outpatient tratment of venous thrombosis]
    2009
  57. Bajuk-Studen Katica; Preželj Janez; Kocjan Tomaž; Pfeifer Marija
    Mehanizmi srčno-žilne orgroženosti žensk s sindormom policističnih ovarijev
    [Mechanisms of cardiovascular disease risks in women with polycystic ovary syndrome]
    2009
  58. Šušteršič Miha; Bunc Matjaž
    Nova spoznanja o reninsko-angiotenzisko-aldosteronskem sistemu in nove strategije njegove zavore
    [New knowledge of renin-angiotensin-aldosterone system and new strategies of its blockade]
    2008
  59. Demers Catherine; McMurray John JV; Swedberg Karl; Pfeffer Marc A; Granger Christopher B; Olofsson Bertil; McKelvie Robert S; Oestergren Jan; Michelson Eric L; Johansson Peter A
    Vpliv kandesartana na neusodni miokardni infarkt in srčno-žilno smrt pri bolnikih s srčno odpovedjo
    [Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure]
    2008
  60. von Haehling Stephan; Lainščak Mitja; Springer Jochen; Anker Stefan D
    Cardiac cachexia: a systematic overview
    2008
  61. Bombek Mirko
    Od hipertenzije do srčnega popuščanja - pomen dvojne zavore renin-angiotenzinskega sistema
    2008
  62. Poredoš P; Jeiovnik MK
    Does the preventive effect of different drugs depend on location of the atherosclerotic process?
    2008
  63. Kogoj Polonca; Hawlina Simin; Bunc Matjaž
    Od endotelija odvisno uravnavanje žilnega napona
    2008
  64. Dzurenkova D; Hruškovičova H; Kovacs L
    Association between athletic performance and insertion/deletion polymorphism of the gene for angiotensin-converting enzyme
    2002
  65. Jakopin Eva; Pečovnik-Balon Breda; Ekart Robert; Ferluga Dušan
    Multiple arterijske tromboze pri bolniku z membranskim glomerulonefritisom
    [Multiple arterial thrombosis in patient with membranous glomerulonephritis]
    2008
  66. Hruškovičova H; Dzurenkova D; Selingerova M; Bohus B; Timkanicova B; Kovacs L
    The angiotensin converting enzyme I/D polymorphism in long distance runners
    2006
  67. Grigore A; Poindexter B; Vaughn WK; Nussmeier N; Frazier OH; Cooper JR; Gregorič ID; Maximilian Buja; Bick RJ
    Alterations in alpha adrenoreceptor density and localization after mechanical left ventricular unloading with the Jarvik flowmaker left ventricular assist device
    2005
  68. Petrovič Daniel
    Optimizing cardiac and vascular protection in hypertensive patients with type 2 diabetes
    2008
  69. Salobir B; Medica I; Terčelj M; Kastrin A; Šabovič M; Peterlin B
    Association of angiotensin-converting enzyme/DD genotype with sarcoidosis susceptibility in Slovenian patients
    2007
  70. Jensterle Mojca; Janež Andrej; Vrtovec Bojan; Meden-Vrtovec Helena; Pfeifer Marija; Preželj Janez; Kocjan Tomaž
    Decreased androgen levels and improved menstrual pattern after angiotension II receptor antagonist Telmisartan treatment in four hypertensive patients with polycistic ovary syndrome: case series
    2007
  71. Osredkar Joško
    Priporočila za uporabo biokemijskih označevalcev pri srčnem popuščanju
    [Recommendations on the use of biochemical markers in heart failure]
    2007
  72. Malnarič Vlasta; Kaplan-Pavlovčič Staša
    Ali arterijsko hipertenzijo pri bolnikih z IgA nefropatijo dobro zdravimo
    [Is arterial hypertension of patients with IgA nephropathy well controlled]
    2007
  73. Petek-Šter Marija; Švab Igor
    Nadzor krvnega tlaka pri bolnikih z arterijsko hipertenzijo v Sloveniji
    [Blood pressure control in patients with arterial hypertension in Slovenia]
    2007
  74. Lainščak Mitja; Cleland John GF; Lenzen Mattie J; Keber Irena; Goode Kevin; Follath Ferenc; Komajda Michel; Swedberg Karl
    Nonpharmacologic measures and drug compliance in patients with heart failure: data from the EuroHeart failure survey
    2007
  75. Virant Mojca
    Vpliv izbranih zaviralcev angiotenzinskega sistema na poškodbe hipoksije-reoksigenacije izolirane prašičje koronarne arterije
    2006
  76. Vrtovec Bojan
    Zdravljenje z zdravili po prebolelem miokardnem infarktu
    2007
  77. Šabovič Mišo
    Pomen zaviralcev angiotenzinske konvertaze pri zdravljenju ishemične bolezni srca
    [The role of ACE inhibitors in the treatment of coronary artery disease]
    2007
  78. Blinc A; Poredoš P
    Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease
    2007
  79. Glavnik N; Petrovič D
    M235T polymorphism of the angiotensinogen gene and insertion/deletion polymorphism of the angiotensin-1 converting enzyme gene in essential arterial hypertension in caucasians
    2007
  80. Lainščak Mitja; Cleland John GF; Lenzen Mattie J; Follath Ferenc; Komajda Michel; Swedberg Karl
    International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart failure survey
    2007
  81. Kolšek Borut
    Neželeni učinki zdravil, ki delujejo na os renin-angiotenzin-aldosteron
    2006
  82. Lovrečić L; Ristić S; Starcević-Čizmarević N; Jazbec ; Sepcić J; Kapović M; Peterlin B
    Angiotensin-converting enzyme I/D gene polymorphism and risk of multiple sclerosis
    2006
  83. Keber Irena
    Pomen antagonistov aldosterona pri zdravljenju kroničnega srčnega popuščanja
    2006
  84. Medica Igor; Kastrin Andrej; Peterlin Borut
    Genetic polymorphisms in vasoactive genes and preeclampsia: a meta-analysis
    2007
  85. Godec Manca; Sinkovič Andreja
    Gastrointestinal bleeding after primary percutaneous coronary intervention in acute coronary syndrome with ST-elevation on electrocardiogram - case report and review of literature
    [Krvavitev iz prebavil po primarni perkutani koronarni intervenciji zaradi akutnega koronarnega sindroma z elevacijo ST segmenta v elektrokardiogramu - prikaz primera in pregled literature]
    2006
  86. Žemva Aleš; Benca Maja
    From endothelial dysfunction to hypertension
    [Od endotelijske disfunkcije do hipertenzije]
    2006
  87. Lainščak Mitja; Keber Irena
    Primary care physicians beliefs concerning heart failure management: results of a cross-sectional survey
    [Prepričanja zdravnikov na primarni ravni o obravnavi srčnega popuščanja: rezultati presečne raziskave]
    2006
  88. Gužič-Salobir Barbara
    Pomen renin-angiotenzinskega sistema pri bolnikih s srčnim popuščanjem
    [The meaning of renin-angiotensin system with patients who have heart failure]
    2006
  89. Keber Irena
    Posodobljene evropske smernice za obravnavo kroničnega srčnega popuščanja - kaj je novega pri farmakološkem zdravljenju
    [The updated European guidelines for the treatment of chronical heart failure - what is new in pharmacological treatment]
    2006
  90. Jug Borut; Šebeštjen Miran; Šabovič Mišo; Keber Irena
    Clopidogrel is associated with a lesser increase in NT-proBNP when compared to aspirin in patients with ischemic heart failure
    2006
  91. Eržen Barbara; Gradišek Primož; Poredoš Pavel; Šabovič Mišo
    Treatment of essential arterial hypertension with enalapril does not result in normalization of endothelial dysfunction of the conduit arteries
    2006
  92. Lipnik-Štangelj Metoda
    Farmakološko zdravljenje arterijske hipertenzije
    2006
  93. Ferjan Mateja; Goličnik Alenka
    Vpliv aktivacije vnetnega odgovora na anemijo pri bolnikih s srčnim popuščanjem
    2005
  94. Klemenc Matjaž
    Zdravljenje bolnika s stabilno angino pektoris z inhibitorji angiotenzinske konvertaze in zaviralci receptorjev za angiotenzin II
    2006
  95. Zorc-Pleskovič Ruda; Teran Nataša; Pleskovič Aleš; Milutinović Aleksandra
    Deletion/deletion genotype of angiotensin-I converting enzyme gene is not associated with coronary artery disease in Caucasians with type 2 diabetes
    2005
  96. Poredoš P
    Prevention of different atherosclerotic diseases: does the effect of preventive measures depend on location of the atherosclerotic process?
    2006
  97. Oestlund Pernilla; Kilk Kalle; Lindgren Maria; Haellbrink Mattias; Jiang Yang; Budihna Metka; Černe Katarina; Bavec Aljoša; Oestenson Claes-Goran; Zorko Matjaž
    Cell-penetrating mimics of agonist-activated G-protein coupled receptors
    2005
  98. Terzić Rifet; Letonja Mitja; Terzić Ibrahim; Šehić Amela; Merić Muharem; Teran Nataša
    Insertion/deletion polymorphism of angiotensin-converting enzyme gene - risk factor for coronary artery disease in the Tuzla region population (Bosnia and Herzegovina)
    [Insercijski/delecijski polimorfizam u genu angiotenzin konvertirajučeg enzima (ACE) - čimbenik rizika bolesti koronarnih arterija u stanovništvu Tuzlanske regije (Bosna i Herzegovina)]
    2003
  99. Vrtačnik-Bokal Eva; Meden-Vrtovec Helena; Verdenik Ivan
    Uterine arterial blood flow and the substances of ovarian rennin-angiotensin system in women with polycystic ovaries undergoing in vitro fertilization
    2006
  100. Černe Andreja; Kranjec Igor; Peterlin Borut
    Angiotensin-converting enzyme gene polymorphism and acute coronary syndrome
    [Polimorfizmi gena za encim angiotenzinsko konvertazo pri bolnikih z akutnim koronarnim sindromom]
    2005

1 101 201 301  


Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko